CalciMedica
CALC
27 hedge funds and large institutions have $37M invested in CalciMedica in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 12 reducing their positions, and 17 closing their positions.
30% less call options, than puts
Call options by funds: $887K | Put options by funds: $1.26M
34% less funds holding
Funds holding: 41 → 27 (-14)
42% less capital invested
Capital invested by funds: $63.7M → $37M (-$26.7M)
75% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 12
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$433K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$361K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$328K |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$16.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.22M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$883K |
| 3 |
VF
Virtu Financial
New York
|
-$358K |
| 4 |
HF
HRT Financial
New York
|
-$153K |
| 5 |
Bessemer Group
Woodbridge,
New Jersey
|
-$146K |
CALC Hedge Fund Activity: Q3 2021 in Review
27 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q3 2021, worth a combined $37M — down 42% from $63.7M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of CALC and 4 opened new positions — a net loss of 13 holders — while 12 trimmed existing stakes and 3 added.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $433K. The largest seller was Morgan Stanley, cutting an estimated $1.22M.
- 27 institutional investors held CalciMedica (CALC) as of Q3 2021, down from 41 in Q2 2021.
- Funds reported $37M of CalciMedica stock for Q3 2021, down 42% quarter-over-quarter.
- 4 funds opened new CalciMedica positions in Q3 2021 and 17 closed out, a net change of -13 holders.
- The largest CalciMedica buyer in Q3 2021 was JP Morgan Chase, an estimated $433K added.
- The largest CalciMedica seller in Q3 2021 was Morgan Stanley, an estimated $1.22M sold.
Based on aggregated 13F filings for Q3 2021.